Among other things, the project will investigate the extent to which eryptosis is a biomarker for nutritional status and cardiovascular health. Eryptosis involves the controlled breakdown of red blood cells (erythrocytes) before the end of their 120-day lifespan.
Furthermore, the extent to which eryptosis is influenced by vitamin D status will be analysed. In addition to eryptosis, the 25-hydroxyvitamin D (25(OH)D) levels in the serum of approximately 2,000 participants at the NAKO site in Halle will also be examined.
